Company profile: Zystor
1.1 - Company Overview
Company description
- Provider of enzyme replacement therapies under development for the treatment of lysosomal storage diseases; privately held biotechnology company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Zystor
Rare Thyroid Therapeutics
HQ: Sweden
Website
- Description: Provider of late-stage orphan drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rare Thyroid Therapeutics company profile →
Akebia Therapeutics
HQ: United States
Website
- Description: Provider of treatments for ischemia and vascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akebia Therapeutics company profile →
Altimmune
HQ: United States
Website
- Description: Provider of vaccines and other biological products to address unmet market and public health needs, using proprietary non-invasive intranasal delivery to stimulate robust and durable immune responses for prevention; programs include pemvidutide, a GLP-1/glucagon dual receptor agonist being developed for obesity and for metabolic dysfunction-associated steatohepatitis (MASH). Proof of principle shown in animals and initial human clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altimmune company profile →
Standard Bariatrics
HQ: United States
Website
- Description: Provider of surgical instruments for weight-loss surgeries, focused on sleeve gastrectomy. Offerings include Titan SGS, a surgical stapler with a 23 cm continuous staple line for consistent sleeve anatomy; Standard Precision Bougie Device for precise alignment and protection of the incisura angularis; Standard Trocar, a bladeless access device for introducing Titan SGS; and Standard Clamp to plan and hold the staple line, helping standardize technique and improve efficiency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Standard Bariatrics company profile →
XOMA
HQ: United States
Website
- Description: Provider of biotech royalty aggregation through acquiring economic rights to future milestone and royalty payments from pre-commercial clinical candidates and commercial therapies, supported by a royalty portfolio of licenses; also provider of antibody discovery and development via a phage display platform, with developing assets including ebopiprant and an anti-prolactin antibody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XOMA company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Zystor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Zystor
2.2 - Growth funds investing in similar companies to Zystor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Zystor
4.2 - Public trading comparable groups for Zystor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →